Dr. Keith Jarvi, Urologist, Toronto, ON

. Jarvi is the Director of the Murray Koffler Urologic Wellness Centre and Head of Urology at the Mount Sinai Hospital. He is a Professor of Surgery at the University of Toronto and directs the Male Infertility Program at the University of Toronto. Dr. Jarvi completed his Urology Residency at the University of Toronto and then had Fellowship training in Male Reproduction with Dr. Dale McClure at the University of California at San Francisco and a basic science fellowship in Male Reproduction supervised by Dr. Claude Gagnon at McGill University in Montreal. Dr. Jarvi then began the Male Reproductive Medicine program at the University of Toronto. This program is a centre of excellence for the management of male infertility and has grown into the largest clinical program of its kind in Canada and one of the largest in North America. Close to 1000 new patients are seen yearly with over 5000 patient visits. The program involves a multi-disciplinary team from Pathology and Laboratory Medicine, Department of Medical Imaging, Medical Genetics and Obstetrics and Gynecology. The centre acts as a tertiary referral centre for difficult infertility cases. At the clinic, patients are seen from all over Canada and from many parts of the world. Dr. Jarvi has been at the forefront of the use of new and innovative surgical techniques in Canada. He was the first in Canada to perform sperm aspiration for in-vitro fertilization, use a minimally invasive technique to retrieve sperm, use the sperm mapping procedure to retrieve sperm, use the newest technique of micro-surgical reconstruction of an obstruction of the reproductive tract. He has also developed innovative techniques of surgery which are now in widespread use. These include a minimally invasive technique to perform a vasectomy reversal and techniques to surgically bridge gaps in the reproductive tract. Dr. Jarvi has helped train over 20 urology fellows, 45 urology residents, 20 gynecology fellows, 20 gynecology residents, 5 graduate students, 4 undergraduate students and innumerable medical students. The urology fellows have gone on to develop their own centres for the treatment of male infertility in hospitals all across Canada, the United States, South America and the Middle East. Dr. Jarvi’s research has focused on: Biomarkers to diagnose male infertility (work funded by PSI and Canadian Urology Association); Genetic causes of male infertility; Cystic fibrosis mutations were identified by our group in a high proportion of men with infertility (supported by NIH, Cystic Fibrosis Foundation of Canada); Novel mutations where he has found novel mutations in men with infertility (supported by CIHR) sperm DNA damage; Infection in male infertility (supported by NIH, PSI, Kidney Foundation); Identification of novel non-cultureable infections in prostatitis (supported by NIH, PSI); Identification of new biomarkers for the early detection of prostate cancer: (supported by the Canadian Urology Association). Dr. Jarvi has published over 70 articles in peer reviewed journals, has been an invited speaker in North and South America, Europe and the Middle East and acts as an advisor to the Government of Canada on issues related to male infertility.

is in good standing with the Canadian Urological Society and the Canadian Medical Association

Keywords: Cancer: BPH, Cancer: Prostate Nutrition, Cancer: Breast Cancer, Cancer: Colon and Rectal Cancer Cancer: Lung Cancer, Cancer: Melanoma, Cancer: Ovarian Cancer, Cancer: Prostate Cancer

( Dr. Keith Jarvi, Urologist, Toronto, ON) is in good standing with the College of Physicians and Surgeons.

If you are looking for local services or  treatment froma local urologist   in the office or hospital from a Urologist, contact a provider such as ( Dr. Keith Jarvi ) to inquire if they are accepting patients or you need a referral.   Phone number to book an appointment (416) 586-4800 Ext. 8867  ( Dr. Keith Jarvi ) Is in good standing with the College of Physicians and Surgeons ( Dr. Keith Jarvi ) Is in good standing with the Canadian Urological Society ( Dr. Keith Jarvi ) Is in good standing with the Canadian Medical Association

Keywords: Cancer: BPH, Cancer: Prostate Nutrition, Cancer: Breast Cancer, Cancer: Colon and Rectal Cancer Cancer: Lung Cancer, Cancer: Melanoma, Cancer: Ovarian Cancer, Cancer: Prostate Cancer

The speaker in the video may have no association with ( Dr. Keith Jarvi, Urologist Toronto, ON ). 
( Dr. Keith Jarvi, Urologist Toronto, ON ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Urologist  about the information you learnt from the videos in regards to Male incontinence Contino® treatments and procedures the Local Urologist  could  perform and if they would be appropriate for you. Remember good information from your Local Urologist  is the corner stone to understanding your condition or disease.

Health Talks:

Sexual preservation for BPH prostate surgery

Urology Practice isa great pleace to start to look into If you’re experiencing symptoms of male incontinence, a local urologist can help. A local urologist can ask about your symptoms and recommend further testing or male incontinence treatment. Urethral inserts like Contino® are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Damage to the kidneys can lead to swelling in the hands and ankles, high blood pressure, and other symptoms. 

Please contact ( Dr. Keith Jarvi, Urologist Toronto, ON ) to enquire if this health care provider is accepting new patients. Prostate Cancer NOW is part of the Now Health Network and its focus is on muscular and skeletal  conditions.  In summary, there are many different treatments for prostate cancer.  Identifying the best treatment will depend on your specific situation and your preference after discussion with your doctor. It is not true Asian men have the lowest risk of developing prostate cancer. African men have the highest risk. Often seeing a local urologist in Toronto can help. 

Medications like alpha blockers don't actually treat BPH, they treat the symptoms by relaxing the muscle around the urethra, so thereby reducing some of the resistance.

Sometimes we will add in a second line medication in order to try and shrink the prostate. These medications are called the five alpha reductase inhibitors. So we have Proscar or Avodart These are medications which work by lowering the conversion of testosterone within the prostate. Over a period of 6 to 12 months, this can shrink the prostate by around 20%.